| Ineffective esophageal motility (IEM)(the primary finding in patients with nonspecific esophageal motility disorder) LP Leite, BT Johnston, J Barrett, JA Castell, DO Castell Digestive diseases and sciences 42, 1859-1865, 1997 | 367 | 1997 |
| Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism S Murin, PS Romano, RH White Thrombosis and haemostasis 88 (09), 407-414, 2002 | 358 | 2002 |
| Shortening the timeline of pediatric phase I trials: the rolling six design JM Skolnik, JS Barrett, B Jayaraman, D Patel, PC Adamson Journal of Clinical Oncology 26 (2), 190-195, 2008 | 289 | 2008 |
| MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. K Peerlinck, I De Lepeleire, M Goldberg, D Farrell, J Barrett, E Hand, ... Circulation 88 (4), 1512-1517, 1993 | 253 | 1993 |
| Physiologically based pharmacokinetic (PBPK) modeling in children JS Barrett, O Della Casa Alberighi, S Läer, B Meibohm Clinical Pharmacology & Therapeutics 92 (1), 40-49, 2012 | 214 | 2012 |
| Population pharmacokinetic studies in pediatrics: issues in design and analysis B Meibohm, S Läer, JC Panetta, JS Barrett The AAPS journal 7, E475-E487, 2005 | 213 | 2005 |
| Pharmacokinetics and pharmacodynamics of MK‐383, a selective non‐peptide platelet glycoprotein‐IIb/IIIa receptor antagonist, in healthy men JS Barrett, G Murphy, K Peerlinck, ID Lepeleire, RJ Gould, D Panebianco, ... Clinical Pharmacology & Therapeutics 56 (4), 377-388, 1994 | 186 | 1994 |
| Population pharmacokinetics of fluconazole in young infants KC Wade, D Wu, DA Kaufman, RM Ward, DK Benjamin Jr, JE Sullivan, ... Antimicrobial agents and chemotherapy 52 (11), 4043-4049, 2008 | 172 | 2008 |
| Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings JS Barrett, MJ Fossler, KD Cadieu, MR Gastonguay The Journal of Clinical Pharmacology 48 (5), 632-649, 2008 | 169 | 2008 |
| Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization JS McCune, MJ Bemer, JS Barrett, K Scott Baker, AS Gamis, NHG Holford Clinical Cancer Research 20 (3), 754-763, 2014 | 160 | 2014 |
| Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor SA Mousa, S Mohamed Thrombosis and haemostasis 92 (09), 627-633, 2004 | 153 | 2004 |
| Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function I Mahé, M Aghassarian, L Drouet, K Lacut, JJ Heilmann, D Mottier, ... Thrombosis and haemostasis 97 (04), 581-586, 2007 | 149 | 2007 |
| Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis X Zuo, CM Ng, JS Barrett, A Luo, B Zhang, C Deng, L Xi, K Cheng, Y Ming, ... Pharmacogenetics and genomics 23 (5), 251-261, 2013 | 147 | 2013 |
| Melatonin pharmacokinetics following two different oral surge‐sustained release doses in older adults NS Gooneratne, AYZ Edwards, C Zhou, N Cuellar, MA Grandner, ... Journal of pineal research 52 (4), 437-445, 2012 | 143 | 2012 |
| Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6 BJ Gertz, JS Barrett, R Eisenhandler, DA Krupa, JM Wittreich, JR Seibold, ... The Journal of Clinical Endocrinology & Metabolism 77 (5), 1393-1397, 1993 | 143 | 1993 |
| A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms A Zajicek, MJ Fossler, JS Barrett, JH Worthington, R Ternik, G Charkoftaki, ... The AAPS journal 15, 1072-1081, 2013 | 141 | 2013 |
| Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography–electrospray ionization mass spectrometry JI Lee, M Narayan, JS Barrett Journal of Chromatography B 845 (1), 95-103, 2007 | 140 | 2007 |
| Moricizine bioavailability via simultaneous, dual, stable isotope administration: bioequivalence implications HJ Pieniaszek Jr, M Mayersohn, MP Adams, RJ Reinhart, JS Barrett The Journal of Clinical Pharmacology 39 (8), 817-825, 1999 | 140 | 1999 |
| Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography–electrospray tandem mass spectrometry JI Lee, BH Hsu, D Wu, JS Barrett Journal of Chromatography A 1116 (1-2), 57-68, 2006 | 137 | 2006 |
| Population pharmacokinetics and pharmacodynamics of ciclesonide S Rohatagi, V Arya, K Zech, R Nave, G Hochhaus, BK Jensen, JS Barrett The Journal of Clinical Pharmacology 43 (4), 365-378, 2003 | 137 | 2003 |
Peter C. AdamsonChildren's Hospital of Philadelphia/UPennDirección de correo verificada de email.chop.edu
